Skyscape Web Viewer : Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs : Main Index

View All
Fab
Fc
FcR
FCR
Fc receptor (FcR)
FDA
FDR
FdUMP
fixed dose rate (FDR)
FK-506 binding proteins (FKBP)
FK-binding proteins (FKBPs)
FKBP
FKBPs
FLT3
Flu
fludarabine, cyclophosphamide, rituximab (FCR) Antimetabolites: Hydroxyurea, Pyrimidine and Purine Analogs, and L-Asparaginase Question 11.5 Question 3.1
fludarabine (Flu)
fluorodeoxyuridine monophosphate (FdUMP)
FMS-like tyrosine kinase 3 (FLT3)
folate receptor (FR)
Folates
Folic acid cell physiology cycle, conversion of dUMP to dTMP role in metabolism
folylpolyglutamyl synthetase (FPGS)
Food and Drug Administration (FDA) Anticancer Drug Development: An Introduction Basic Drug Development With Structural Considerations Drug Approval and Regulatory Issues Immunotherapeutics Including Vaccines, Bispecifics, CAR-T, and Checkpoint Inhibitors Multiple Myeloma as a Paradigm for Multi-Targeted Intervention Question 18.1 Targeted Therapies (Small Molecules)
F-PG
FPGS
FR
fragment antigen-binding (Fab)
fragment crystallizable (Fc)